Epidemiology of vascular disease in renal failure

Blood Purification

Volumn 20, Issue 1, 2002, Pages 6-10

  Ikizler, T Alp ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Hemodialysis; Inflammation; Mortality

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; HEART INFARCTION; HEMODIALYSIS; HUMAN; MORBIDITY; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UREMIA; INFLAMMATION; KIDNEY FAILURE; REVIEW; UNITED STATES;

CARDIOVASCULAR DISEASES; HUMAN; INFLAMMATION; KIDNEY FAILURE; KIDNEY FAILURE, CHRONIC; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES; HUMANS;

EID: 0036007318     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046979     Document Type: Article

References (33)

1. Excerpts from the USRDS 1997 annual data report
2. Excerpts from the USRDS 2001 annual data report
3. Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns and opportunities
4. Epidemiologic approaches to heart disease: The Framingham study
5. Serum creatinine levels in the US population: Third national health and nutrition examination survey
6. Cardiovascular disease in end-stage renal disease patients
7. USRDS dialysis morbidity and mortality study: Wave 2. United States renal data system
8. The US renal data system and the case mix severity study
9. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
10. Cardiac disease in chronic uremia: Clinical outcome and risk factors
11. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
12. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
13. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
14. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease
15. Cardiovascular disease and chronic renal disease: A new paradigm
16. Cardiovascular disease determinants in chronic renal failure: Clinical approach and treatment
17. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
18. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
19. Atherosclerosis - An inflammatory disease
20. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study
21. Immunologic function and survival in hemodialysis patients
22. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
23. Acute-phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients
24. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
25. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
26. The microinflammatory state in uremia: Causes and potential consequences
27. Evidence for hemodialysis induced inflammation
28. Insulin resistance in uremia
29. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
30. Acute-phase proteins and other systemic responses to inflammation
31. Inflammatory and atherosclerotic interactions in the depleted uremic patient
32. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure